Summary: Researchers uncovered the first direct empirical evidence of how genetic mutation severity alters sex-based vulnerability to autism spectrum disorder. Historically, autism is diagnosed roughly four times more frequently in males than females, leading scientists to suspect a natural female biological protection mechanism.
The researchers successfully engineered the world’s first viable homozygous CHD8-mutant mouse model, targeting one of the most critical genetic risk factors for autism. The study reveals that while mild genetic mutations spare females, severe mutations completely overwhelm female biological defenses, causing pronounced autism-related abnormalities across both sexes.
Key Facts
- The Four-Fold Sex Gap: Autism spectrum disorder naturally affects males far more frequently than females, maintaining a diagnostic ratio of approximately 4:1 in boys.
- The Chromatin Master Switch: CHD8 is a high-ranking genetic risk factor for autism. The gene acts as a structural remodeling agent for chromatin, effectively regulating a vast downstream network of other genes critical to early brain development.
- Breaking the Embryonic Barrier: Previous attempts to breed mice with mutations in both copies of the CHD8 gene (homozygous mutants) resulted in embryonic death. By deploying a unique hybrid genetic background, the Korean team bypassed this limitation to create viable, living severe-mutation models.
- The Mutation Severity Shift: While mice with a single mutated CHD8 copy (heterozygous) expressed behavioral abnormalities strictly in males, the severe double-mutated homozygous models displayed devastating autism traits in both males and females.
- Widespread Neural Disruption: The severe homozygous mutation triggered structural and physiological cascades, including enlarged brain volume, altered cerebral blood flow, destabilized brain rhythms, and massive genetic transcriptomic changes damaging synaptic signaling, RNA splicing, and mitochondrial functions.
- Fluid Sex Differences: The findings prove that the biological mechanisms protecting females against autism are not static or fixed; instead, female resilience progressively breaks down based on the absolute intensity of the genetic disruption.
Source: Institute for Basic Science
Autism spectrum disorder affects males far more frequently than females, with diagnoses occurring roughly four times more often in boys.
Scientists have long suspected that females may possess biological protective mechanisms that reduce vulnerability to autism, but direct experimental evidence has remained limited.
A joint research team from KAIST, Yonsei University, and Institute for Basic Science has now uncovered evidence that the severity of autism-related genetic mutations may play a key role in overcoming these protective effects.
The researchers developed the world’s first viable homozygous CHD8-mutant mouse model and discovered that stronger mutations can dramatically alter the male–female pattern of autism-related symptoms.
CHD8 is considered one of the most important genetic risk factors for autism spectrum disorder and other neurodevelopmental conditions. The gene helps regulate the activity of many other genes involved in brain development by remodeling chromatin structure.
However, previous animal models carrying only a single mutated CHD8 copy often showed relatively mild symptoms, limiting researchers’ ability to investigate severe forms of the disorder.
Attempts to generate mice carrying mutations in both CHD8 copies had previously failed because the animals died during embryonic development.
To overcome this problem, the team introduced the mutation into a hybrid genetic background, allowing the mice to survive. This enabled researchers to directly compare mild and severe CHD8 mutations across brain development, neural activity, behavior, and gene expression.
The results revealed a striking shift in autism-related traits.
Mice carrying only one mutated CHD8 copy showed behavioral abnormalities primarily in males, consistent with previous findings and the higher prevalence of autism in human males. In contrast, mice carrying severe mutations in both CHD8 copies displayed pronounced autism-related abnormalities in both sexes.
The homozygous mutant mice also exhibited enlarged brain volume, altered cerebral blood flow, disrupted brain rhythms, and widespread transcriptomic changes involving synaptic signaling, RNA splicing, and mitochondrial function — pathways strongly associated with autism and other neurodevelopmental disorders.
“Our findings suggest that females may possess protective biological mechanisms against CHD8-related dysfunction, but severe mutations can overwhelm those protective effects,” said Professor LEE Eunee of Yonsei University.
“This provides important insight into why autism severity and sex differences can vary depending on genetic background and mutation strength.”
The researchers found that many male–female differences became progressively weaker as mutation severity increased. This suggests that the biological mechanisms underlying sex differences in autism may not be fixed, but instead depend on the intensity of genetic disruption.
Beyond autism, the findings may also help explain sex differences observed in other neurodevelopmental disorders linked to CHD8, including ADHD, intellectual disability, and schizophrenia.
Director KIM Eunjoon of the IBS Center for Synaptic Brain Dysfunctions stated, “Through this study using a viable homozygous CHD8 mutant mouse model, we have comprehensively elucidated the developmental mechanisms of severe autism at both the brain circuit and genetic levels.”
He added, “By proving for the first time that sex differences in autism vary according to mutation strength, we have established an important foundation for the future development of precision therapeutics that account for both biological sex and severity.”
Key Questions Answered:
A: For decades, scientists have observed that boys are diagnosed with autism roughly four times more often than girls, strongly indicating that females carry natural, built-in biological protective mechanisms that act as an invisible shield against neurodevelopmental disorders. However, capturing exactly how this shield works has been incredibly difficult. This study provides the missing piece of the puzzle: it proves that the shield works beautifully against minor genetic glitches, but can be entirely shattered if the underlying mutation is deep and aggressive enough.
A: The CHD8 gene is so load-bearing for the structural layout of a developing brain that previous animal models carrying a double mutation in both copies would consistently die before ever being born. To solve this critical bottleneck, the combined KAIST, Yonsei, and IBS team creatively introduced the mutation into a specialized, hybrid genetic background. This genetic safety net allowed the severe double-mutant mice to survive embryonic development, giving science its first living look at severe autism pathology across both sexes.
A: On the contrary, it means biological sex matters immensely, but it must be viewed through the lens of mutation strength. By demonstrating for the first time that sex differences vanish as a genetic mutation becomes more severe, the study establishes a critical foundation for precision medicine. Future therapeutic interventions can now be tailored specifically to a patient’s exact genetic background, accounting for the fluid relationship between their biological sex and the severity of their condition.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this autism and genetics research news
Author: William Suh
Source: Institute for Basic Science
Contact: William Suh – Institute for Basic Science
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Homozygous CHD8 mutation intensifies ASD phenotypes and attenuates sex differences” by Jinkyeong Kim, Seungjoon Lee, Eunkyu Hwang, Hwajin Jung, Chanhee Lee, Sang-Han Choi, Sooyeon Lee, Seongbin Kim, Heera Moon, Jisoo Kim, Gina Lee, Yong Gyu Kim, Soogeun Shin, Hyojin Kang, Se Jin Kim, Heon Yung Gee, Seong-Gi Kim, Eunee Lee & Eunjoon Kim. Molecular Psychiatry
DOI:10.1038/s41380-026-03646-9
Abstract
Homozygous CHD8 mutation intensifies ASD phenotypes and attenuates sex differences
CHD8 is a chromatin remodeler implicated in autism spectrum disorders (ASD) and multiple neurodevelopmental disorders, yet heterozygous Chd8-mutant mouse lines often exhibit only mild ASD-related phenotypes, leaving its role unclear.
Because a complete knockout of Chd8 causes embryonic lethality, we generated viable homozygous Chd8-mutant mice carrying the human CHD8-Asn2373LysfsX2 mutation using a hybrid (C57BL6/J × 129/Sv) genetic background.
Compared to heterozygous Chd8+/N2373K mice, the homozygous Chd8N2373K/N2373K mice showed more robust phenotypes, including increased ASD-related behaviors and brain volume, decreased cerebral blood volume/flow, brain rhythms, and synaptic transmission, and ASD-related transcriptomic changes.
Notably, while Chd8+/N2373K mice on a pure background predominantly displayed behavioral deficits in males, the homozygous mutants in the hybrid background exhibited more pronounced female phenotypes, suggesting the interaction of genetic background and mutation strength.
A direct comparison of Chd8+/N2373K and Chd8N2373K/N2373K mice on the same hybrid background across brain volume, cerebral blood flow, neuronal firing, synaptic transmission, and transcriptome revealed a gene dosage-dependent attenuation of sexual dimorphic phenotypes that varied by developmental stage and brain region.
Transcriptomic analyses further implicated pathways related to synaptic function, RNA splicing, and mitochondrial activity in mediating differences in male–female protection and susceptibility.
Thus, a homozygous Chd8 mutation not only intensifies ASD-related traits but can also diminish typical sex-specific severity patterns, uncovering a novel link between mutation strength and sexual dimorphism in ASD.
